Session Details
[29-55-am]Pharmaceutics 8/Clinical Pharmacy 30
Sun. Mar 29, 2026 9:30 AM - 11:30 AM JST
Sun. Mar 29, 2026 12:30 AM - 2:30 AM UTC
Sun. Mar 29, 2026 12:30 AM - 2:30 AM UTC
Room 55 (C202, Bldg. 2, Area 2 [2F]) (2)
Discusser: Sayo Suzuki, Yasuhiro Masubuchi
[29-55-am-08]Design of an absorbable and sustaining oral formulation combining mucus penetrating PEGylated liposomes and polysaccharides
○Eriko Yamazoe1, Sora Nishida1, Takaaki Ito1, Kohei Tahara1 (1. Gifu Pharmaceutical University)
[29-55-am-09]Prophylactic effect of DDS formulation with antioxidant properties on chemotherapy-induced myelosuppression
○Mikako Shimoda1, Ayano Shikata1, Yusuke Murakami1,2, Masahiro Kawahara1,2, Tohru Mizushima3, Ken-Ichiro Tanaka1,2 (1. Musashino Univ., Fac. Pharm. , 2. Musashino Univ., Res. Ins. Pharm. Sci., 3. LTT Bio-Pharma Co., Ltd)
[29-55-am-10]Variation in basal and phenobarbital-induced expression of cytochrome P450 in mice model of metabolic dysfunction associated steatohepatitis
○Chieri Fujino1, Yukine Kubo1, Satoshi Ueshima1, Toshiya Katsura1 (1. College of Pharm. Sci., Ritsumeikan Univ.)
[29-55-am-11]Molecular interaction of ceramide/cholesterol for understanding of barrier function of stratum corneum
○Shu Mao1, Ishida Kenya2, Yuri Ikeuchi1, Yasuko Obata1 (1. Hoshi.Univ., 2. Takasago International Corporation)
[29-55-am-12]The effect of drug-induced acute kidney injury on the plasma concentration of cimetidine
○Yuichi Ichimura1, Mizuki Toda1, Kazuki Shirota1, Masako Oda1, Hiroshi Saitoh1 (1. Health Sciences University of Hokkaido)
[29-55-am-13]Effect of selective serotonin reuptake inhibitors on the expression of drug-metabolizing enzymes in Caco-2 cells
○Ayaka Kojima1, Yuichi Uwai1, Tomohiro Nabekura1 (1. Sch. Pharm., Aichi-Gakuin Univ.)
[29-55-am-14]Current status and challenges in metabolic evaluation for nucleic acid therapeutics development
○Yutaka Niwayama1,2, Tsubasa Kameyama1,3, Tatsuya Yamakawa1,4, Nobuyoshi Hasebe1,5 (1. JPMA, 2. KYORIN PHARMACEUTICAL, 3. NIPPON SHINYAKU, 4. FUJIFILM Toyama Chemical, 5. The Research Foundation for Microbial Diseases of Osaka Univ.)